RÉSUMÉ
Limited information is available on the epidemiology of hypertriglyceridemia (HTG; 150-499 mg/dL) and severe HTG (SHTG; >500 mg/dL) in children. This study estimates the prevalence of HTG and SHTG, evaluates factors that may be associated with these conditions, and describes the use of dyslipidemic agents in children. The sample included children 12 to 19 years old who participated in National Health and Nutrition Examination Survey (NHANES) 2001-2008 (n = 3248) and children 5 to 19 years of age who were part of a large managed-care claims database in the United States (n = 65 258). Results from NHANES confirm the rarity of SHTG in the US pediatric population (ie, 0.2%). Factors statistically significantly associated with having HTG or SHTG in the claims database were being male, 12 to 19 years old, having high low-density lipoprotein (LDL), having low high-density lipoprotein (HDL), diabetes, and psychological disorders. Fibrates were the most commonly prescribed triglyceride-lowering agent among children with SHTG, followed by statins and Lovaza.
Sujet(s)
Hypertriglycéridémie/épidémiologie , Triglycéride/sang , Adolescent , Facteurs âges , Enfant , Enfant d'âge préscolaire , Études transversales , Complications du diabète , Femelle , Humains , Hypertriglycéridémie/sang , Hypertriglycéridémie/traitement médicamenteux , Hypertriglycéridémie/étiologie , Hypolipémiants/usage thérapeutique , Lipoprotéines HDL/sang , Lipoprotéines LDL/sang , Modèles logistiques , Mâle , Troubles mentaux/complications , Enquêtes nutritionnelles , Projets pilotes , Prévalence , Facteurs de risque , Facteurs sexuels , États-Unis/épidémiologie , Jeune adulteRÉSUMÉ
OBJECTIVE: Find conditions with significantly different prevalence among employees diagnosed with morbid obesity (DMO). Examine the effect of bariatric surgery on the prevalence of all categories of comorbid conditions after surgery. METHODS: This large employer retrospective database analysis used matching to create two cohorts: Those with a DMO and those without. RESULTS: The DMO cohort had higher diagnosis rates in every Agency for Healthcare Research and Quality major diagnostic category except pregnancy, and it had significantly higher prevalence in 147 of 261 Agency for Health care Research and Quality specific categories. Those electing to undergo bariatric surgery experienced significant prevalence decreases in 26 of 261 specific categories. CONCLUSION: Employees DMO are at higher risk for many serious diseases. Bariatric surgery has been effective in promoting weight loss and decreasing the rates of many serious comorbidities.
Sujet(s)
Chirurgie bariatrique , Comorbidité , Obésité morbide/chirurgie , Adulte , Emploi , Femelle , Humains , Mâle , Obésité morbide/épidémiologie , Prévalence , Études rétrospectives , Facteurs de risque , Résultat thérapeutique , États-Unis/épidémiologieRÉSUMÉ
This article addresses the observational findings of the first systematic study undertaken by a manufacturer to address the impact of allergies and use of allergy medications on health, safety, and productivity. It provides background for 3 other papers from the same project, including an evaluation of an intervention to promote appropriate medication use among affected employees, which appear in this issue. The observational data are developed on 10,714 employees from: 1) 2 employee surveys; 2) administrative databases monitoring employee absenteeism, workers compensation, short-term disability, and group health. The results show that health, productivity, absenteeism, workplace injury, and workers compensation measures register consistent declines as allergy severity levels increase. This pattern is present but less pronounced for the short-term disability and group health measures. In addition, among the 16 measures registering a significant allergy burden, 6 posted significant advantages for the use of nonsedating antihistamines relative to other medication regimens that included sedative antihistamines. These results document the burden of allergies and the capacity of medications to reduce this burden. Effective intervention programs that target this condition can achieve improved health, productivity, and related outcomes.
Sujet(s)
Absentéisme , Hypersensibilité/épidémiologie , Métallurgie , Exposition professionnelle/effets indésirables , Indemnisation des accidentés du travail/économie , Adulte , Allergènes/effets indésirables , Coûts indirects de la maladie , Collecte de données , Évaluation de l'invalidité , Rendement , Études d'évaluation comme sujet , Femelle , Humains , Hypersensibilité/diagnostic , Mâle , Adulte d'âge moyen , Indice de gravité de la maladie , Enquêtes et questionnaires , États-Unis/épidémiologie , Lieu de travailRÉSUMÉ
This work presents the evaluation of a first-of-its-kind intervention to improve the management of allergies among workers in a largely blue-collar industrial setting. This intervention implemented eight educational strategies focusing on appropriate medication use in the context of a controlled, nonrandomized, pre-post quasi-experimental study design. Program implementation occurred during summer 2001, with change assessed by means of measures of health and productivity, developed from employee surveys timed to occur at the height of the spring and fall allergy seasons, and measures of contemporaneous adverse events developed from administrative databases. Evidence of improvement was found at one experimental site but not at the other experimental sites or the control site. Tests using exploratory and confirmatory analyses were conducted of two hypotheses linking the gains of this site's allergy group to 1) intervention process changes and 2) changes in allergy severity caused by seasonality. Neither hypothesis is found to fully account for the explained variation between sites. Similar pre-post productivity gains for other disease groups at this site relative to the other sites suggest that the inclusion of other unmeasured variables would improve explanation; e.g., the responses of employees with chronic disease to notably challenging labor negotiations at this site. The implications for promoting behavioral change in the management of the impact of disease on productivity are explored.